[HTML][HTML] Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

…, F Krauer, S Raina, J Young, KM Rentsch… - … England Journal of …, 2010 - Mass Medical Soc
Background In autosomal dominant polycystic kidney disease (ADPKD), aberrant activation
of the mammalian target of rapamycin (mTOR) pathway is associated with progressive …

St John's Wort induces intestinal P‐glycoprotein/MDR1 and intestinal and hepatic CYP3A4

…, GA Kullak‐Ublick, KM Rentsch… - Clinical …, 2000 - Wiley Online Library
Background St John's Wort (hypericum perforatum) is an herbal medicine that is frequently
used for therapy of mild depression. Recently, St John's Wort was reported to substantially …

Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization

…, L Steiner, L Gurke, T Breidthardt, K Rentsch… - Circulation, 2018 - Am Heart Assoc
Background: Perioperative myocardial injury (PMI) seems to be a contributor to mortality
after noncardiac surgery. Because the vast majority of PMIs are asymptomatic, PMI usually is …

[HTML][HTML] Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids*♦

…, MM Reilly, H Houlden, M Laurá, K Rentsch… - Journal of biological …, 2010 - ASBMB
HSAN1 is an inherited neuropathy found to be associated with several missense mutations
in the SPTLC1 subunit of serine palmitoyltransferase (SPT). SPT catalyzes the condensation …

Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre …

…, A Fischer, HB Gaspar, U Schanz, R Seger, K Rentsch… - The Lancet, 2014 - thelancet.com
Background In chronic granulomatous disease allogeneic haemopoietic stem-cell
transplantation (HSCT) in adolescents and young adults and patients with high-risk disease is …

The importance of stereoselective determination of drugs in the clinical laboratory

KM Rentsch - Journal of biochemical and biophysical methods, 2002 - Elsevier
About 56% of the drugs currently in use are chiral compounds, and 88% of these chiral
synthetic drugs are used therapeutically as racemates. Only a few of these drugs qualify for a …

Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay

…, I Campodarve, R Bingisser, Ò Miró, K Rentsch… - Cmaj, 2015 - Can Med Assoc
Background: We aimed to prospectively validate a novel 1-hour algorithm using high-sensitivity
cardiac troponin T measurement for early rule-out and rule-in of acute myocardial …

Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction

…, P Hillinger, C Puelacher, K Rentsch… - Circulation, 2015 - Am Heart Assoc
Background— It is unknown whether more sensitive cardiac troponin (cTn) assays maintain
their clinical utility in patients with renal dysfunction. Moreover, their optimal cutoff levels in …

One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I

…, T Herrmann, I Campodarve, K Rentsch… - The American journal of …, 2015 - Elsevier
Objective We aimed to prospectively derive and validate a novel 1h-algorithm using high-sensitivity
cardiac troponin I (hs-cTnI) for early rule-out and rule-in of acute myocardial infarction…

Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction

…, J Voegele, B Hartmann, K Rentsch… - European heart …, 2014 - academic.oup.com
Aim It is unknown whether cardiac troponin (cTn) I or cTnT is the preferred biomarker in the
early diagnosis of acute myocardial infarction without ST segment elevation (NSTEMI). …